{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:33:13Z","timestamp":1794493993972,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Optimal composition of intestinal bacteria is an essential condition for good health. Excessive growth of these bacteria can cause various ailments. The aim of this study was to assess the mental state and gastrointestinal complaints of patients with small intestinal bacterial overgrowth (SIBO) in relation to tryptophan metabolism and rifaximin treatment.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>120 subjects, aged 23\u201361\u00a0years, were enrolled in the study, and divided into 3 groups, 40 individuals each: healthy subjects (Controls), patients with SIBO and chronic diarrhea (SIBO-D), and with chronic constipation (SIBO-C). The lactulose hydrogen breath test (LHBT) was performed to diagnose SIBO. The mental state of patients was assessed using the Hamilton Anxiety Rating Scale (HAM-A), and the Hamilton Depression Rating Scale (HAM-D). L-tryptophan (TRP) and its metabolites: 5-hydroxyindoleacetic acid (5-HIAA), kynurenine (KYN), xanthurenic acid (XA) and quinolinic acid (QA) were measured in urine by liquid-chromatography-tandem mass spectrometry and related to creatinine level. Patients with SIBO were recommended to take rifaximin for 10\u00a0days at daily dose 1200\u00a0mg, and this cycle was repeated in subsequent two months.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mild and moderate anxiety, as well as mild depression were diagnosed in all SIBO patients. Changes in TRP metabolism were also observed in these patients. Specifically, an increase in the activity of the serotonin pathway of TRP metabolism in the group SIBO-D was observed. The SIBO-C patients showed an increase in the concentration of KYN, XA and QA. 5-HIAA\/TRP and KYN\/TRP ratios significantly decreased in group SIBO-D, and KYN and QA levels decreased in group SIBO-C after treatment with rifaximin. The levels of anxiety and depression decreased in both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Rifaximin treatment of SIBO patients ameliorated their mood disorders and gastrointestinal aliments underlined by changes in tryptophan metabolism.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Retrospectively registered (if applicable).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12986-022-00700-5","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:03:05Z","timestamp":1664265785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth"],"prefix":"10.1186","volume":"19","author":[{"given":"Cezary","family":"Chojnacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pop\u0142awski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Fila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"B\u0142asiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Chojnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"700_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"13","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microb. 2018;13:716\u201324.","journal-title":"Cell Host Microb"},{"key":"700_CR2","doi-asserted-by":"crossref","unstructured":"Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microb. 2012; 3(1):4.","DOI":"10.4161\/gmic.19320"},{"key":"700_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SGA.0000000000000369","volume":"42","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Duriancik DM. Management of small intestinal bacterial overgrowth in adult patients. Gastroenterol Nurs. 2019;42:269\u201376.","journal-title":"Gastroenterol Nurs"},{"key":"700_CR4","doi-asserted-by":"publisher","unstructured":"Tsiotsias A, Voidarou C, Skoufos J, Simopoulos C, Konstandi M. Kostakis D, Bezirtzoglou E. Stress-induced alterations in intestinal microflora. Microb Ecol Health Dis. 2004; https:\/\/doi.org\/10.1080\/08910600410028632.","DOI":"10.1080\/08910600410028632"},{"issue":"1","key":"700_CR5","first-page":"15","volume":"19","author":"B Sobieszcza\u0144ska","year":"2012","unstructured":"Sobieszcza\u0144ska B. The influence of stress on the gastrointestinal tract. Gastroenterol Pol. 2012;19(1):15\u201320.","journal-title":"Gastroenterol Pol"},{"key":"700_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fcimb.2020.00468","volume":"10","author":"C Carco","year":"2020","unstructured":"Carco C, Young W, Gearry RB, Talley NJ, McNabb WC. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 2020;10:468. https:\/\/doi.org\/10.3389\/fcimb.2020.00468.","journal-title":"Front Cell Infect Microbiol"},{"key":"700_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","volume":"45","author":"L Gatta","year":"2017","unstructured":"Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Therap. 2017;45:604\u201316.","journal-title":"Aliment Pharmacol Therap"},{"key":"700_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.015","volume":"38","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun. 2014;38:1\u201312.","journal-title":"Brain Behav Immun"},{"key":"700_CR9","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203\u20139 (PMID: 25830558).","journal-title":"Ann Gastroenterol"},{"key":"700_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacol. 2017;112:399\u2013412.","journal-title":"Neuropharmacol"},{"key":"700_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32\u201348.","journal-title":"Behav Brain Res"},{"key":"700_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","volume":"1693","author":"P Strandwitz","year":"2018","unstructured":"Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128\u201333.","journal-title":"Brain Res"},{"key":"700_CR13","doi-asserted-by":"publisher","unstructured":"Chuah KH, Wong MS, Tan PO, Lim SZ, Beh, KH, Chong SCS et al. Small intestinal bacterial overgrowth in various functional gastrointestinal disorders: a case-control study. Dig Dis Sci 2021: https:\/\/doi.org\/10.1007\/s10620-021-07227-4.","DOI":"10.1007\/s10620-021-07227-4."},{"key":"700_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5009\/gnl.2011.5.1.29","volume":"5","author":"HS Cho","year":"2011","unstructured":"Cho HS, Park JM, Lim CH, Cho YK, Lee IS, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver. 2011;5:29\u201336.","journal-title":"Gut Liver"},{"key":"700_CR15","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3748\/wjg.v21.i10.3072","volume":"21","author":"T Didari","year":"2015","unstructured":"Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World Gastroenterol. 2015;21:3072\u201384.","journal-title":"World Gastroenterol"},{"key":"700_CR16","doi-asserted-by":"crossref","unstructured":"Le Morvan de Sequeira C, Kaeber M, Cekin SE, Enck P, Mack I. The effect of probiotics on quality of life, depression and anxiety in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Clin Med. 2021; 10: 3497.","DOI":"10.3390\/jcm10163497"},{"key":"700_CR17","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1038\/s41598-021-81654-1","volume":"11","author":"H Tran","year":"2021","unstructured":"Tran H, Sagi V, Jarrett S, Palzer EF, Badgaiyan RD, Gupta K. Diet and companionship modulate pain via a serotonergic mechanism. Sci Rep. 2021;11:2330. https:\/\/doi.org\/10.1038\/s41598-021-81654-1.","journal-title":"Sci Rep"},{"key":"700_CR18","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1096\/fj.14-259598","volume":"29","author":"CS Reigstad","year":"2015","unstructured":"Reigstad CS, Salmonson SE, Rainey JF, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2015;29:1395\u2013403.","journal-title":"FASEB J"},{"key":"700_CR19","doi-asserted-by":"crossref","unstructured":"Arnone D, Saraykar S, Salem H, Teixeira A L, Dantzer R, Selvaraj S. Role of kynurenine pathway and its metabolites in mood disorders: a systematic review and meta-analysis of clinical studies. Neurosci Biobeh Rev. 2018; 92: 477\u2013485.","DOI":"10.1016\/j.neubiorev.2018.05.031"},{"key":"700_CR20","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"15","author":"AA Badawy","year":"2017","unstructured":"Badawy AA. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res\u202f: IJTR. 2017;15:1178646917691938. https:\/\/doi.org\/10.1177\/1178646917691938.","journal-title":"Int J Tryptophan Res : IJTR"},{"key":"700_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","volume":"48","author":"AM Myint","year":"2014","unstructured":"Myint AM, Kim YK. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:304\u201313.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"700_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU12103183","volume":"12","author":"C Chojnacki","year":"2020","unstructured":"Chojnacki C, Pop\u0142awski T, Chojnacki J, Fila M, Konrad P, Blasiak J. Tryptophan intake and metabolism in older adults with mood disorders. Nutrients. 2020;12:1\u201311. https:\/\/doi.org\/10.3390\/NU12103183.","journal-title":"Nutrients"},{"key":"700_CR23","first-page":"1551","volume":"1191","author":"A Evrensel","year":"2020","unstructured":"Evrensel A, \u00dcnsalver B\u00d6, Ceylan ME. Immune-kynurenine pathways and the gut microbiota-brain axis in anxiety disorders. AdvExp Med Biol. 2020;1191:1551\u201367.","journal-title":"AdvExp Med Biol"},{"key":"700_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/7854_2016_12","volume":"31","author":"J Savitz","year":"2017","unstructured":"Savitz J. Role of kynurenine metabolism pathway activation in major depressive disorders. Curr Top Behav Neurosci. 2017;31:249\u201368.","journal-title":"Curr Top Behav Neurosci"},{"key":"700_CR25","doi-asserted-by":"publisher","unstructured":"Cervenka I, Agudelo LZ, Ruas JL. Kynurenines. Tryptophan\u2019s metabolism in exercise inflammation and mental health. Science. 2017; https:\/\/doi.org\/10.1126\/science.eaaf9794.","DOI":"10.1126\/science.eaaf9794"},{"key":"700_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immun Cell Biol. 2003;81:247\u201365.","journal-title":"Immun Cell Biol"},{"key":"700_CR27","unstructured":"Chojnacki C, Mikulska P, Knopik-Dabrowicz A, Kaczka A, Chojnacki J, Konrad P. The role of intraepithelial lymphocytes in pathogenesis of small intestinal bacterial overgrowth. Polish Med J 2021, XLIX(289), 391\u201393, PMID 33713088."},{"key":"700_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","volume":"112","author":"H Fuiigaki","year":"2017","unstructured":"Fuiigaki H, Yamammoto Y, Saito K. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Neuropharmacol. 2017;112:264\u201374.","journal-title":"Neuropharmacol"},{"key":"700_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3109\/00365521.2014.936034","volume":"49","author":"A Berstad","year":"2014","unstructured":"Berstad A, Raa J, Valeur J. Tryptophan: \u2018essential\u2019 for the pathogenesis of irritable bowel syndrome? Scand J Gastroenterol. 2014;49:1493\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"700_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-230X-9-6","volume":"20","author":"G Clarke","year":"2009","unstructured":"Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol. 2009;20(9):6. https:\/\/doi.org\/10.1186\/1471-230X-9-6.","journal-title":"BMC Gastroenterol"},{"key":"700_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jpsychores.2013.01.008","volume":"74","author":"D Keszthelyi","year":"2013","unstructured":"Keszthelyi D, Troost FJ, Jonkers DM, Kruimel JW, Leue C, Masclee AA. Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state. J Psychosom Res. 2013;74:501\u20134.","journal-title":"J Psychosom Res"},{"key":"700_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.nutres.2010.09.009","volume":"30","author":"DM Christmas","year":"2010","unstructured":"Christmas DM, Badawy A, Hince D, Davies S, Probert CSJ, Creed T, et al. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome. Nutrition Res. 2010;30:678\u201388.","journal-title":"Nutrition Res"},{"key":"700_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1365-2982.2008.01195.x","volume":"20","author":"P Fitzgerald","year":"2008","unstructured":"Fitzgerald P, Cassidy Eugene M, Clarke G, Scully P, Barry S, et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric Co-morbidity. Neurogastroenterol a Motil. 2008;20:1291\u20137.","journal-title":"Neurogastroenterol a Motil"},{"key":"700_CR34","doi-asserted-by":"crossref","unstructured":"Young S N. The Effect of Raising and Lowering Tryptophan Levels on Human Mood and Social Behaviour. Philos Trans o R Soc Lond B Biol Sci. 2013; 368(1615): 20110375.","DOI":"10.1098\/rstb.2011.0375"},{"key":"700_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/NU12030710","volume":"12","author":"B Klimova","year":"2020","unstructured":"Klimova B, Novotny M, Valis M. The impact of nutrition and intestinal microbiome on elderly depression: a systematic review. Nutrients. 2020;12:710. https:\/\/doi.org\/10.3390\/NU12030710.","journal-title":"Nutrients"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00700-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-022-00700-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00700-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:07:29Z","timestamp":1664266049000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-022-00700-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["700"],"URL":"https:\/\/doi.org\/10.1186\/s12986-022-00700-5","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the principle of Good Clinical Practice. Written consent was obtained from each subject enrolled in the study and the study protocol was approved by The Bioethics Committee of Medical University of Lodz (RNN\/176\/18\/KE).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"66"}}